Navigation Links
Essilor Strengthens its Polarized Lens Distribution Network With the Acquisition of KBco
Date:10/1/2007

CHARENTON-LE-PONT, France, October 2 /PRNewswire-FirstCall/ -- Essilor of America, a subsidiary of Essilor International, has acquired a majority stake in KBco, one of the largest polarized lens distributors in the United States.

Created in 1987 and based in Centennial, Colorado, KBco generates sales of around $31 million. A recognized specialist in polarized lenses for the US ophthalmic optics industry, it supplies retail chains and eye care professionals with a broad offering of innovative high quality products.

The acquisition enhances Essilor's portfolio of value-added corrective sun lenses and expands its presence in the fast-growing polarized segment.

KBco will keep its current management team.

Essilor International is the world leader in ophthalmic optical products, offering a wide range of lenses under the flagship Varilux(R), Crizal(R), Airwear(R), Definity(TM) and Essilor(R) brands to correct myopia, hyperopia, presbyopia and astigmatism. Essilor operates worldwide through 15 production sites, 244 lens finishing laboratories and local distribution networks. The Essilor share trades on the Euronext Paris market and is included in the CAC 40 index. Codes and symbols: ISIN: FR 0000121667; Reuters: ESSI.PA; Bloomberg: EF:FP.

Investor Relations and Financial Communications

Veronique Gillet

Phone: +33-1-49-77-42-16

http://www.essilor.com


'/>"/>
SOURCE Essilor
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Magnesium In Diet Strengthens Bones
2. MSU Research Strengthens Link Between Smoking, Pancreatic Cancer
3. Medication recuperates fat distribution in diabetes
4. Arrest of Professor over Distribution of Banned Drug
5. Distribution of Flu Vaccines Unpredictable
6. Free Condoms Distribution to Prevent HIV in Washington
7. A Better Understanding Of The Brain Network
8. A first in Liver Transplant in India – Networking works wel
9. 20 Men Involved In Gay Sex Network Acquire HIV Infection
10. New Network To Ease Blood donation In India
11. "Daydreaming" Network Fails In Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:ADA Urges President Bush Not to Veto Critical Appropriations Bill 2Health News:AUA releases new guidelines on non-muscle invasive bladder cancer 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 2Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 3Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 4Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 5Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 6Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 7Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 8Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 9Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 10Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 11Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 12Health News:Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007 13Health News:New Study: Health Insurance Mandates on Employers Hurt Low-Income Employees 2Health News:Physics provides new insights on cataract formation 2
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 1Call to the Youth of America 3A Palms for Life Fund Launches Film Competition to Document Hunger in the United States 53180 2All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 1All Nursing Schools Sheds Light on Online Nursing Degree Opportunities in a Rough Economy 53176 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 1Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 2Higher drug doses needed to defeat tuberculosis UT Southwestern researchers report 53172 3